Early Parkinson’s Treatment Options Now Include Neurostimulation
Neurostimulation is an accepted form of treatment for advanced Parkinson’s disease, but a recent study confirmed that it can be used in early stages of the disease to improve the quality of life of patients.
Kristina Fiore of MedPage Today reports that there is already a faction of doctors across the country that are using neurostimulation early in the treatment of Parkinson’s. This report is still valuable, however, as it confirms those doctors’ thinking and establishes this option for mainstream treatment.
There are, however, some adverse effects to be considered with neurostimulation. During the study, researchers found that depression is more common for patients undergoing neurostimulation treatments. There is also a risk of brain abscess and edema, but all cases during the study were “resolved completely.”
One other aspect to take into consideration, this study dealt exclusively with patients under the age of 60 and none were suffering from dementia, which is atypical of Parkinson’s patients. An additional study would be needed to find how neurostimulation would affect those older patients and those with dementia.